G
Galectin Therapeutics D
D
GALT
3.61000
USD
-0.15
(-3.91%)
مغلق
حجم التداول
5,079
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
228,482,622
الأخبار المقالات
العنوان: Galectin Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.